Tag

Coronavirus

Tampa Bay Company Searching for Other Vaccine Methods

UF startup and UF Innovate | Sid Martin Biotech graduate Oragenics, Inc., a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis, is in the pre-clinical phase of developing a vaccine they say would solve two critical problems when it comes to ending the pandemic.

Everything You Need To Know About Vaccines and COVID-19

Dr. Peter Khoury, president and CEO of UF startup and UF Innovate | Sid Martin Biotech graduate Ology Bioservices, Inc., a biologics contract development and manufacturing organization (CDMO), talked with James Di Virgilio, Radio Cade's host, about vaccinations and COVID-19.

Oragenics Chases Vaccine for Niche Markets

UF startup and UF Innovate | Sid Martin Biotech graduate Oragenics, a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis, seeks to be a major player in the Super Bowl of the pharmaceutical industry: a COVID-19 vaccine.

Dr. Cindy Prins Assesses Spaces Across UF Campus for COVID-19 Transmission Risks

In her role as the infection preventionist for the UF Health Screen, Test and Protect Program, Cindy Prins, Ph.D., clinical associate professor of epidemiology and assistant dean for educational affairs for the UF College of Public Health and Health Professions, offers infection control assessments for UF entities who aim to resume activities throughout campus.

SARS-CoV-2 Spike Protein Licensed by Oragenics From the NIH Demonstrates Protective Immunity in Mice

UF startup and UF Innovate | Sid Martin Biotech graduate company Oragenics, Inc., a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis, announces that the stabilized pre-fusion spike protein CoV-2 S-2P created by the National Institutes of Health (“NIH”) and licensed by the Company demonstrates protective immunity in immunized mice challenged with mouse-adapted SARS-CoV-2 virus.